Wolverine Trading, LLC Vanda Pharmaceuticals Inc. Put Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$3.91 - $6.5 $43,010 - $71,500	11,000 New	11,000 $62,000
Q2 2020 Aug 13, 2020	SELL	$9.66 - $12.02 $99,498 - $123,806	-10,300 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$7.5 - $16.8 $7,500 - $16,800	-1,000 Reduced 8.85%	10,300 $100,000
Q4 2019 Feb 12, 2020	BUY	$12.38 - $17.47 $139,894 - $197,411	11,300 New	11,300 $185,000
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $128,835 - $165,795	-10,500 Closed	0 $0
Q2 2019 Aug 20, 2019	SELL	$13.37 - $18.85 $104,286 - $147,030	-7,800 Reduced 42.62%	10,500 $148,000
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $109,058 - $192,510	6,200 Added 51.24%	18,300 $337,000
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $22,764 - $37,764	1,200 Added 11.01%	12,100 $310,000
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $153,145 - $220,180	10,900 New	10,900 $184,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $282M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.